Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice

被引:112
作者
Leroy, Karelle
Bretteville, Alexis
Schindowski, Katharina
Gilissen, Emmanuel
Authelet, Michele
De Decker, Robert
Yilmaz, Zehra
Buee, Luc
Brion, Jean-Pierre
机构
[1] Univ Libre Bruxelles, Lab Histol Neuroanat & Neuropathol, Sch Med, B-1070 Brussels, Belgium
[2] Jean Pierre Aubert Res CTr, Fac Med, INSERM, U837, Lille, France
[3] Jean Pierre Aubert Res CTr, Fac Med, Inst Med Predictive & Rech Therapeut, Lille, France
关键词
D O I
10.2353/ajpath.2007.070345
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Neurodegenerative diseases characterized by brain and spinal cord involvement often show widespread accumulations of tau aggregates. We have generated a transgenic mouse line (Tg30tau) expressing in the forebrain and the spinal cord a human tau protein bearing two pathogenic mutations (P301S and G272V). These mice developed age-dependent brain and hippocampal atrophy, central and peripheral axonopathy, progressive motor impairment with neurogenic muscle atrophy, and neurofibrillary tangles and had decreased survival. Axonal spheroids and axonal atrophy developed early before neurofibrillary tangles. Neurofibrillary inclusions developed in neurons at 3 months and were of two types, suggestive of a selective vulnerability of neurons to form different types of fibrillary aggregates. A first type of tau-positive neurofibrillary tangles, more abundant in the forebrain, were composed of ribbon-like 19-nm-wide -filaments and twisted paired helical filaments. A second type of tau and neurofilament-positive neurofibrillary tangles, more abundant in the spinal cord and the brainstem, were composed of 10-nm-wide neurofilaments and straight 19-nm filaments. Unbiased stereological analysis indicated that total number of pyramidal neurons and density of neurons in the lumbar spinal cord were not reduced up to 12 months in mice. This T930tau model thus provides evidence that axonopathy precedes tangle formation and that both lesions can be dissociated from overt neuronal loss in selected brain areas but not from neuronal dysfunction.
引用
收藏
页码:976 / 992
页数:17
相关论文
共 73 条
[1]  
Allen B, 2002, J NEUROSCI, V22, P9340
[2]   Tau function and dysfunction in neurons - Its role in neurodegenerative disorders [J].
Avila, J ;
Lim, F ;
Moreno, F ;
Belmonte, C ;
Cuello, AC .
MOLECULAR NEUROBIOLOGY, 2002, 25 (03) :213-231
[3]   Increased tau phosphorylation but absence of formation of neurofibrillary tangles in mice double transgenic for human tau and Alzheimer mutant (M146L) presenilin-1 [J].
Boutajangout, A ;
Leroy, K ;
Touchet, N ;
Authelet, M ;
Blanchard, V ;
Tremp, G ;
Pradier, L ;
Brion, JP .
NEUROSCIENCE LETTERS, 2002, 318 (01) :29-33
[4]   Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1 [J].
Boutajangout, A ;
Authelet, M ;
Blanchard, V ;
Touchet, N ;
Tremp, G ;
Pradier, L ;
Brion, JP .
NEUROBIOLOGY OF DISEASE, 2004, 15 (01) :47-60
[5]   SYNAPTOPHYSIN AND CHROMOGRANIN-A IMMUNOREACTIVITIES IN SENILE PLAQUES OF ALZHEIMERS-DISEASE [J].
BRION, JP ;
COUCK, AM ;
BRUCE, M ;
ANDERTON, B ;
FLAMENTDURAND, J .
BRAIN RESEARCH, 1991, 539 (01) :143-150
[6]   NEUROFILAMENT MONOCLONAL-ANTIBODIES RT97 AND 8D8 RECOGNIZE DIFFERENT MODIFIED EPITOPES IN PAIRED HELICAL FILAMENT-TAU IN ALZHEIMERS-DISEASE [J].
BRION, JP ;
COUCK, AM ;
ROBERTSON, J ;
LOVINY, TLF ;
ANDERTON, BH .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (04) :1372-1382
[7]   Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease [J].
Brion, JP ;
Tremp, G ;
Octave, JN .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (01) :255-270
[8]   A68 PROTEINS IN ALZHEIMERS-DISEASE ARE COMPOSED OF SEVERAL TAU ISOFORMS IN A PHOSPHORYLATED STATE WHICH AFFECTS THEIR ELECTROPHORETIC MOBILITIES [J].
BRION, JP ;
HANGER, DP ;
COUCK, AM ;
ANDERTON, BH .
BIOCHEMICAL JOURNAL, 1991, 279 :831-836
[9]   Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology [J].
Bronner, IF ;
ter Meulen, BC ;
Azmani, A ;
Severijnen, LA ;
Willemsen, R ;
Kamphorst, W ;
Ravid, R ;
Heutink, P ;
van Swieten, JC .
BRAIN, 2005, 128 :2645-2653
[10]   Tau protein isoforms, phosphorylation and role in neurodegenerative disorders [J].
Buée, L ;
Bussière, T ;
Buée-Scherrer, V ;
Delacourte, A ;
Hof, PR .
BRAIN RESEARCH REVIEWS, 2000, 33 (01) :95-130